|
|
ZURICH (Reuters) - Novartis' lung drug Onbrez Breezhaler allows patients with a deadly lung disease to breathe more easily than a current mainstay treatment, adding to positive sentiment surrounding the Swiss drugmaker. (Source: Reuters: Health)
Read from Source
|
| |
| |
| | 123 |
| |
|
|
|
|
|
|
